SCHEMBL4834153

SCHEMBL4834153

O=C1C2CC3C(=O)N(OS(=O)(=O)c4ccc(C(F)(F)F)cc4)C(=O)C3CC2C(=O)N1OS(=O)(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.41
PARL Q9H300 2/20 0.41
ENPP3 O14638 4/20 0.40
ENPP1 P22413 3/20 0.40
ENPP2 Q13822 3/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
KIF11 P52732 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
NOX4 Q9NPH5 1/20 0.37
VDR P11473 1/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4831892 0.86 KMT2A (0.43) PTGS2PARLENPP3ENPP1ENPP2
SCHEMBL4834762 0.85 GAA (0.36) PARLKMT2AMEN1
SCHEMBL4831931 0.84 KMT2A (0.55) PTGS2PARLENPP3ENPP1ENPP2
SCHEMBL548362 0.83 NOX4 (0.39) PTGS2PARLENPP3ENPP1ENPP2
SCHEMBL4826369 0.83 CA1 (0.43) PARLKMT2ACA1CA2MMP2
SCHEMBL4831889 0.83 LIPE (0.44) PTGS2PARLKMT2AMEN1HTR2A
SCHEMBL503643 0.81 PARL (0.62) PTGS2PARLENPP3ENPP1ENPP2
SCHEMBL6420670 0.81 KMT2A (0.39) PTGS2PARLENPP3ENPP1ENPP2
SCHEMBL4832240 0.80 KDM4E (0.50) PARLKMT2AMEN1CA2MMP2
SCHEMBL4837175 0.80 ALDH1A1 (0.50) PARLKMT2AMEN1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 PTGS2 2630/4885PARL 1086/4885ENPP3 3980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.